CytomX Therapeutics, Inc. (CTMX)
3.71
+0.07
(+1.92%)
USD |
NASDAQ |
May 20, 16:00
3.71
0.00 (0.00%)
Pre-Market: 20:00
CytomX Therapeutics Profit Margin (Quarterly) : -177.9% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Rigel Pharmaceuticals, Inc. | 14.71% |
| Ovid Therapeutics, Inc. | -- |
| Gossamer Bio, Inc. | -275.2% |
| Mirum Pharmaceuticals, Inc. | -494.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.05% |
| Return on Assets | -31.34% |
| Return on Invested Capital | -42.30% |
| Gross Profit Margin (Quarterly) | 97.55% |
| Operating Margin (Quarterly) | -191.8% |
| Return on Net Operating Assets | -629.2% |